Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Nanosphere-mediated co-delivery of VEGF-A and PDGF-B genes for accelerating diabetic foot ulcers healing in rats

Abstract

Diabetic ischemic ulcer is an intractable diabetic complication. Angiogenesis is a critical factor for wound healing in patients with diabetic foot wounds. Sustained gene delivery could be notably necessary in modulating gene expression in chronic ulcer healing and might be a promising approach for diabetic foot ulcers. In the present study, Sprague–Dawley rats were used to establish diabetic foot ulcer models by streptozotocin and skin biopsy punch. The plasmids expressing VEGF-A and PDGF-B were prepared and then incorporated with polylactic-co-glycolic acid (PLGA) nanospheres to upregulate genes expression. The aim of this study was to explore whether the engineered VEGF-A and PDGF-B based plasmid-loaded nanospheres could be upregulated in streptozotocin-induced diabetic rats and improve the wound healing. The cultured fibroblasts could be effectively transfected by means of nanosphere/plasmid in vitro. In vivo, the expression of VEGF-A and PDGF-B was significantly upregulated at full-thickness foot dorsal skin wounds and the area of ulceration was progressively and significantly reduced following treatment with nanosphere/plasmid. These results indicated that combined gene transfer of VEGF-A and PDGF-B could improve reparative processes in the wounded skin of diabetic rats and nanosphere may be a potential non-viral vector for gene therapy of the diabetic foot ulcer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

References

  1. Ramachandran A, Snehalatha C, Shetty AS, Nanditha A. Trends in prevalence of diabetes in Asian countries. World J Diabetes. 2012;3:110–7.

    Article  Google Scholar 

  2. Cavanagh P, Attinger C, Abbas Z, Bal A, Rojas N, Xu ZR. Cost of treating diabetic foot ulcers in five different countries. Diabetes Metab Res Rev. 2012;28:107–11.

    Article  Google Scholar 

  3. Boyko EJ, Ahroni JH, Smith DG, Davignon D. Increased mortality associated with diabetic foot ulcer. Diabetes Med. 1996;13:967–72.

    Article  CAS  Google Scholar 

  4. Oliveira N, Rosa P, Borges L, Dias E, Oliveira F, Cássio I. Treatment of diabetic foot complications with hyperbaric oxygen therapy: a retrospective experience. Foot Ankle Surg. 2014;20:140–3.

    Article  CAS  Google Scholar 

  5. Petrofsky JS, Lawson D, Berk L, Suh H. Enhanced healing of diabetic foot ulcers using local heat and electrical stimulation for 30 min three times per week. J Diabetes. 2010;2:41–46.

    Article  Google Scholar 

  6. Teng YJ, Li YP, Wang JW, Yang KH, Zhang YC, Wang YJ, et al. Bioengineered skin in diabetic foot ulcers. Diabetes Obes Metab. 2010;12:307–15.

    Article  CAS  Google Scholar 

  7. Bennett SP, Griffiths GD, Schor AM, Leese GP, Schor SL. Growth factors in the treatment of diabetic foot ulcers. Br J Surg. 2003;90:133–46.

    Article  CAS  Google Scholar 

  8. Martin P. Wound healing–aiming for perfect skin regeneration. Science. 1997;276:75–81.

    Article  CAS  Google Scholar 

  9. Koria P. Delivery of growth factors for tissue regeneration and woundhealing. BioDrugs. 2012;26:163–75.

    Article  CAS  Google Scholar 

  10. Werner S, Breeden M, Hubner G, Greenhalgh DG, Longaker MT. Induction of keratinocyte growth factor expression is reduced and delayed during wound healing in the genetically diabetic mouse. J Invest Dermatol. 1994;103:469–73.

    Article  CAS  Google Scholar 

  11. Sprugel KH, McPherson JM, Clowes AW, Ross R. Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers. Am J Pathol. 1987;129:601–13.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Saaristo A, Tammela T, Farkkilā A, Kärkkäinen M, Suominen E, Yla-Herttuala S, et al. Vascular endothelial growth factor-C accelerates diabetic wound healing. Am J Pathol. 2006;169:1080–7.

    Article  CAS  Google Scholar 

  13. Uchi H, Igarashi A, Urabe K, Koga T, Nakayama J, Kawamori R, et al. Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. Eur J Dermatol. 2009;19:461–8.

    PubMed  Google Scholar 

  14. Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen. 1999;7:442–52.

    Article  CAS  Google Scholar 

  15. Hirsch T, Spielmann M, Velander P, Zuhaili B, Bleiziffer O, Fossum M, et al. Insulin-like growth factor-1 gene therapy and cell transplantation in diabetic wounds. J Gene Med. 2008;10:1247–52.

    Article  CAS  Google Scholar 

  16. Patil SD, Rhodes DG, Burgess DJ. DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J. 2005;7:E61–77.

    Article  CAS  Google Scholar 

  17. Wong SP, Argyros O, Harbottle RP. Vector systems for prenatal gene therapy: principles of non-viral vector design and production. Methods Mol Biol. 2012;891:133–67.

    CAS  PubMed  Google Scholar 

  18. Itaka K, Kataoka K. Recent development of nonviral gene delivery systems with virus-like structures and mechanisms. Eur J Pharm Biopharm. 2009;71:475–83.

    Article  CAS  Google Scholar 

  19. Shen J, Zhao DJ, Li W, Hu QL, Wang QW, Xu FJ, et al. A polyethyleniminemimetic biodegradable polycation gene vector and the effect of amine composition in transfection efficiency. Biomaterials. 2013;34:4520–31.

    Article  CAS  Google Scholar 

  20. Tian H, Chen J, Chen X. Nanoparticles for gene delivery. Small. 2013;9:2034–44.

    Article  CAS  Google Scholar 

  21. Smith PJ, Giroud M, Wiggins HL, Gower F, Thorley JA, Stolpe B, et al. Cellular entry of nanoparticles via serum sensitive clathrin-mediated endocytosis, and plasma membrane permeabilization. Int J Nanomed. 2012;7:2045–55.

    CAS  Google Scholar 

  22. De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int J Nanomed. 2008;3:133–49.

    Article  Google Scholar 

  23. Thangarajah H, Yao D, Chang EI, Shi Y, Jazayeri L, Vial IN, et al. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci USA. 2009;106:13505–10.

    Article  CAS  Google Scholar 

  24. Goldman R. Growth factors and chronic wound healing: past, present and future. Adv Skin Wound Care. 2004;17:24–35.

    Article  Google Scholar 

  25. Broughton G, Janis JE, Attinger CE. Wound healing: an overview. Plast Reconstr Surg. 2006;117:1e–32e.

    Article  Google Scholar 

  26. Fang RC, Galiano RD. A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers. Biologics. 2008;2:1–12.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Andrae J, Gallini R, Betsholtz C, Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008;22:1276–312.

    Article  CAS  Google Scholar 

  28. Greenberg JI, Shields DJ, Barillas SG, Acevedo LM, Murphy E, Huang J, et al. A role for VEGF as a negative regulator for pericyte function and vessel maturation. Nature. 2008;11:809–13.

    Article  Google Scholar 

  29. Judith R, Nithya M, Rose C, Mandal AB. Application of a PDGF containing novel gel for cutaneous wound healing. Life Sci. 2010;87:1–8.

    Article  CAS  Google Scholar 

  30. Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, Bastidas N, et al. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol. 2004;164:1935–47.

    Article  CAS  Google Scholar 

  31. Jazwa A, Kucharzewska P, Leja J, Zagorska A, Sierpniowska A, Stepniewski J, et al. Combined vascular endothelial growth factor-A and fibroblast growth factor 4 gene transfer improves wound healing in diabetic mice. Genet Vaccines Ther. 2010;8:6.

    Article  Google Scholar 

  32. Cohen H, Levy RJ, Gao J, Fishbein I, Kousaev V, Sosnowski S, et al. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther. 2000;7:1896–905.

    Article  CAS  Google Scholar 

  33. Francis-Goforth KN, Harken AH, Saba JD. Normalization of diabetic wound healing. Surgery. 2010;147:446–9.

    Article  Google Scholar 

  34. Pendsey SP. Understanding diabetic foot. Int J Diab Dev Ctries. 2010;30:75–79.

    Article  Google Scholar 

  35. Chen C, Schultz GS, Bloch M, Edwards PD, Tebes S, Mast BA. Molecular and mechanistic validation of delayed healing rat wounds as a model for human chronic wounds. Wound Repair Regen. 1999;7:486–94.

    Article  CAS  Google Scholar 

Download references

Funding

This work was supported by the Natural Science Foundation of China [grant number 81071242], the International Exchange Program for Graduate Students, Tongji University [grant number 2016XJKC-014]

Author contributions

RS, WL, SH, and ML contributed to the conception, design, and experiments of the study; manuscript preparation and were responsible for collecting data. SH, CC, YJ, and YY carried out the experiment and analyzed data; RS, WL, HZ, and ML wrote and edited the main manuscript text, and all of the authors discussed the results and proofread on the submitted versions.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Hui Zhao or Maoquan Li.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shi, R., Lian, W., Han, S. et al. Nanosphere-mediated co-delivery of VEGF-A and PDGF-B genes for accelerating diabetic foot ulcers healing in rats. Gene Ther 25, 425–438 (2018). https://doi.org/10.1038/s41434-018-0027-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41434-018-0027-6

This article is cited by

Search

Quick links